Danish Drug Company Novo Nordisk (NVO) With a Stock Market Cap of US$132 Bil Had a Huge 51% of Its 2016 Total Revenues Generated in the US and a Much Lower 15% of Its 2016 Total Property, Plant and Equipment Located in the US
From NVO's US SEC Filings
